People: Henry Schein Inc (HSIC.OQ)
HSIC.OQ on NASDAQ Stock Exchange Global Select Market
105.51USD
1:40pm EDT
105.51USD
1:40pm EDT
Price Change (% chg)
$-0.95 (-0.89%)
$-0.95 (-0.89%)
Prev Close
$106.46
$106.46
Open
$106.34
$106.34
Day's High
$106.34
$106.34
Day's Low
$105.15
$105.15
Volume
59,402
59,402
Avg. Vol
142,555
142,555
52-wk High
$106.81
$106.81
52-wk Low
$72.84
$72.84
Summary
| Name | Age | Since | Current Position |
|---|---|---|---|
Stanley Bergman |
63 | 2005 | Chairman of the Board, Chief Executive Officer |
James Breslawski |
59 | 2005 | President, Chief Operating Officer, Director; Chief Executive Officer of Henry Schein Global Dental Group |
Steven Paladino |
55 | 2000 | Chief Financial Officer, Executive Vice President, Director |
Lonnie Shoff |
54 | 2009 | President and Chief Executive Officer of Global Animal Health and Strategic Partnerships Group |
Michael Zack |
60 | 2006 | President - International Group |
Gerald Benjamin |
2000 | Chief Administrative Officer, Executive Vice President, Director | |
Mark Mlotek |
57 | 2004 | Chief Strategic Officer, Executive Vice President, Director |
James Harding |
2005 | Chief Technology Officer, Senior Vice President | |
Leonard David |
64 | 2006 | Chief Compliance Officer, Senior Vice President |
Michael Racioppi |
58 | 2008 | Senior Vice President, Chief Merchandising Officer |
Stanley Komaroff |
77 | 2003 | Senior Advisor |
Philip Laskawy |
72 | 2012 | Lead Independent Director |
Barry Alperin |
72 | 1996 | Independent Director |
Paul Brons |
71 | 2005 | Independent Director |
Donald Kabat |
77 | 1996 | Independent Director |
Karyn Mashima |
59 | 2008 | Independent Director |
Norman Matthews |
80 | 2002 | Independent Director |
Carol Raphael |
70 | 2012 | Independent Director |
Bradley Sheares |
56 | 2010 | Independent Director |
Louis Sullivan |
79 | 2003 | Independent Director |
Carolynne Borders |
2012 | Vice President - Investor Relations |
Biographies
| Name | Description |
|---|---|
Stanley Bergman |
Mr. Stanley M. Bergman is Chairman of the Board, Chief Executive Officer of Henry Schein Inc. He has been with the Company since 1980, including as Company's Chairman and Chief Executive Officer since 1989 and as a director since 1982. He is also a member of Company's Executive Management Committee. Mr. Bergman held the position of President of the Company from 1989 to 2005. Mr. Bergman held the position of Executive Vice President from 1985 to 1989 and Vice President of Finance and Administration from 1980 to 1985. During his tenure, Mr. Bergman has led the Company from sales of $600 million in 1995 to $8.9 billion in 2012. Mr. Bergman is active in numerous dental industry and professional associations, including the American Dental Association (where he served on the Oversight Committee of the Future of Dentistry Project and was awarded honorary membership) and The Forsyth Institute, the premiere oral health research institution in the United States. Mr. Bergman is also a Certified Public Accountant. |
James Breslawski |
Mr. James P. Breslawski is President, Chief Operating Officer, Director of Henry Schein Inc., and Chief Executive Officer of Henry Schein Global Dental Group of Henry Schein Inc. He has been with the Company since 1980, in his current position as Company's President and Chief Operating Officer since 2005 and as a director since 1992. He is also a member of Company's Executive Management Committee and the Chief Executive Officer of Company's Henry Schein Global Dental Group. Mr. Breslawski held the position of Executive Vice President and President of U.S. Dental from 1990 to 2005, with primary responsibility for the North American Dental Group. Between 1980 and 1990, Mr. Breslawski held various positions with the Company, including Chief Financial Officer, Vice President of Finance and Administration and Corporate Controller. Mr. Breslawski is responsible for the Company’s Global Dental and North American Medical businesses. Mr. Breslawski has served as Chairman of the Board of the American Dental Trade Association and President of the Dental Dealers of America. He is also a member of the Leadership Council, School of Dental Medicine at Harvard University, a former board member of the Dental Life Network (formerly the National Foundation of Dentistry for the Handicapped), a former member of the Board of Governors for St. John’s University and a former trustee of Long Island University. Mr. Breslawski is also a Certified Public Accountant. |
Steven Paladino |
Mr. Steven Paladino is Executive Vice President, Chief Financial Officer, Director of Henry Schein Inc. He has been with the Company for 25 years (since 1987), in his current position as Executive Vice President and Chief Financial Officer for 12 years (since 2000) and as a director for 20 years (since 1992). Prior to holding his current position, Mr. Paladino was Senior Vice President and Chief Financial Officer from 1993 to 2000, from 1990 to 1992 Mr. Paladino served as Vice President and Treasurer and from 1987 to 1990 served as Corporate Controller. Before joining the Company, Mr. Paladino was employed as a public accountant for seven years, most recently with the international accounting firm of BDO Seidman LLP (now known as BDO USA LLP). Mr. Paladino is a Certified Public Accountant. |
Lonnie Shoff |
Ms. Lonnie Shoff is President and Chief Executive Officer of Global Animal Health and Strategic Partnerships Group of Henry Schein Inc., since September 2009. In this position, Ms. Shoff directs Global Dental Specialties business; Global Exclusive Brands; North American animal health business; North American and international dental handpiece repair businesses; and a growing portfolio of joint ventures. Prior to joining the Company, Ms. Shoff was with Roche Diagnostics, where she held a series of positions of increasing responsibility in the United States and Switzerland over the past 20 years, focusing on applied science, molecular diagnostics, global business development, and marketing and business management. Most recently, Ms. Shoff served as Senior Vice President and General Manager, Applied Science, the U.S. commercial operations for this $350 million group. Ms. Shoff has managed the life cycles of more than 2,500 products, launched several novel technologies, and nurtured ventures from seed funding through product launch. |
Michael Zack |
Mr. Michael Zack is President - International Group of Henry Schein Inc., since March 2006. Mr. Zack has been responsible for International Group for 23 years, since 1989 when he joined the Company. Before joining the Company, Mr. Zack was employed by Polymer Technology (a subsidiary of Bausch & Lomb) as Vice President of International Operations from 1984 to 1989. Prior to this, Mr. Zack was employed by Gruenenthal GmbH, a German pharmaceutical company, as Manager of International subsidiaries from 1975 to 1984. As part of his various foreign assignments at Gruenenthal, Mr. Zack worked and lived in Tehran, Iran; Quito, Ecuador; Lima, Peru; Madrid, Spain; and Bogotá, Colombia, before being transferred to Boston, Massachusetts. Mr. Zack is the representative of the Dental Trade Alliance to International Dental Manufacturers. |
Gerald Benjamin |
Mr. Gerald A. Benjamin is Chief Administrative Officer, Executive Vice President, Director of Henry Schein Inc. He has been with the Company since 1988, in his current position as Executive Vice President and Chief Administrative Officer since 2000 and a director since 1994. He is also a member of Company's Executive Management Committee. Prior to holding his current position, Mr. Benjamin was Senior Vice President of Administration and Customer Satisfaction since 1993. Mr. Benjamin was Vice President of Distribution Operations from 1990 to 1992 and Director of Materials Management from 1988 to 1990. Before joining the Company in 1988, Mr. Benjamin was employed at Estée Lauder, Inc. holding various management positions over his 13-year tenure, including Director of Materials Planning and Control. Mr. Benjamin brings experience to the Company’s Board of Directors in the areas of global services, human resources, operations and leadership. Mr. Benjamin oversees operations at Henry Schein’s distribution centers in North America, Europe, Australia and New Zealand, including over 4 million square feet of distribution space. |
Mark Mlotek |
Mr. Mark E. Mlotek is Chief Strategic Officer, Executive Vice President, Director of Henry Schein Inc. He has been Executive Vice President and Chief Strategic Officer since 2004. Mr. Mlotek was Senior Vice President of Corporate Business Development from 2000 to 2004. Prior to that, Mr. Mlotek was Vice President, General Counsel and Secretary from 1994 to 1999 and became a director in 1995. Prior to joining the Company, Mr. Mlotek was a partner in the law firm of Proskauer Rose LLP, counsel to the Company, specializing in mergers and acquisitions, corporate reorganizations and tax law from 1989 to 1994. |
James Harding |
Mr. James A. Harding is Chief Technology Officer, Senior Vice President of Henry Schein Inc. He has been Chief Technology Officer since 2005 and Senior Vice President since 2001. Mr. Harding is responsible for ensuring that information technology remains a competitive advantage for the Company, internally and externally. In this capacity, Mr. Harding leads Technology Group. Mr. Harding was formerly Chief Information Officer at Olsten Corporation, a healthcare and staffing services company. Prior to Olsten, Mr. Harding worked for 20 years at Mobil Oil Corporation in various capacities including Chief Information Officer of the America’s Marketing & Refining Division and Director of Global IT Architecture. |
Leonard David |
Mr. Leonard A. David is Chief Compliance Officer, Senior Vice President of Henry Schein Inc., since March 2006. Mr. David held the position of Vice President and Chief Compliance Officer from 2005 to 2006. Mr. David held the position of Vice President of Human Resources and Special Counsel from 1995 to 2005. Mr. David held the position of Vice President, General Counsel and Secretary from 1990 through 1994 and practiced corporate and business law for eight years prior to joining the Company. |
Michael Racioppi |
Mr. Michael Racioppi is Senior Vice President, Chief Merchandising Officer of Henry Schein Inc., since January 2008. Prior to holding his current position, Mr. Racioppi was President of the Medical Division from 2000 to 2008 and Interim President from 1999 to 2000, and Corporate Vice President from 1994 to 2008. Mr. Racioppi served as Senior Director, Corporate Merchandising from 1992 to 1994. Before joining the Company in 1992, Mr. Racioppi was employed by Ketchum Distributors, Inc. as the Vice President of Purchasing and Marketing. |
Stanley Komaroff |
Mr. Stanley Komaroff, Esq., is Senior Advisor of Henry Schein Inc., since December 2003. He has been with the Company for nine years (since 2003). Prior to joining the Company, Mr. Komaroff served as an advisor on legal and board-related issues and provides experience in the corporate, commercial and healthcare worlds. Mr. Komaroff was formerly the Chairman of Proskauer Rose LLP. Prior to being elected as Chairman of the firm, Mr. Komaroff was the Chair of its Corporate Department. As a general corporate and securities lawyer, Mr. Komaroff has experience in mergers and acquisitions and international transactions. Mr. Komaroff has been active in civic and philanthropic matters. Mr. Komaroff serves on the Board of Directors of Overseas Shipholding Group, Inc. and the Westhampton Beach Performing Arts Center. For more than 10 years, Mr. Komaroff was a member of the New York State Hospital Review and Planning Council, having received multiple gubernatorial appointments to this position. Mr. Komaroff is a member of the Board of Directors of Continuum Health Partners, one of the consortiums of hospitals and healthcare facilities in the New York metropolitan area, and a director of its constituent hospitals, Beth Israel Medical Center and St. Luke’s-Roosevelt Hospital Center. Mr. Komaroff is also a former Board member of The Edmond de Rothschild Foundation. At Mayor Bloomberg’s recommendation, Mr. Komaroff served on the Board of Directors of the New York City Economic Development Corporation from 2006 to 2009. |
Philip Laskawy |
Mr. Philip A. Laskawy is Lead Independent Director of Henry Schein Inc. has been a director since 2002 and has served as Company's Lead Director since 2012. Mr. Laskawy joined the accounting firm of Ernst & Young LLP in 1961 and served as a partner in the firm from 1971 to 2001, when he retired. Mr. Laskawy served in various senior management positions at Ernst & Young, including Chairman and Chief Executive Officer, to which he was appointed in 1994. Mr. Laskawy currently serves on the Board of Directors of General Motors Corporation (and is a member of its finance and risk committee), Lazard Ltd. (and is Chairman of its compensation committee and is a member of its audit committee) and Loews Corporation (and is a member of its audit committee). Mr. Laskawy is also the Non-Executive Chairman of Federal National Mortgage Association (Fannie Mae) (and Chairman of its executive committee). Mr. Laskawy served on the American Institute of Certified Public Accountants to review and update rules regarding auditor independence. In 2006 and 2007, he served as Chairman of the International Accounting Standards Committee Foundation, which was created by the SEC and sets accounting standards in more than 100 countries, and he served as a member of the 1999 Blue Ribbon Committee on Improving the Effectiveness of Corporate Audit Committees. Mr. Laskawy also serves on the boards of non-profit organizations. During the past five years, Mr. Laskawy served on the Board of Directors of The Progressive Corporation and Discover Financial Services. |
Barry Alperin |
Mr. Barry J. Alperin is Independent Director of Henry Schein Inc., since May 1996. Mr. Alperin, who is retired, served as Vice Chairman of Hasbro, Inc. from 1990 through 1995, as Co-Chief Operating Officer of Hasbro from 1989 through 1990 and as Senior Vice President or Executive Vice President of Hasbro from 1985 through 1989. He was a director of Hasbro from 1985 through 1996. Prior to joining Hasbro, Mr. Alperin practiced law in New York City for 20 years, dealing with corporate, public and private financial transactions, corporate mergers and acquisitions, compensation issues and securities law matters. Mr. Alperin currently serves as a director of Fiesta Restaurant Group, Inc. (and is Chairman of its finance committee and a member of its audit and corporate governance and nominating committees) and is a director of two privately held corporations, K’NEX Industries, Inc., a toy manufacturer, and Weeks Marine, Inc., a marine construction company (and its subsidiary McNally Construction Co., Inc.). During the past five years, Mr. Alperin served on the Board of Directors of K-Sea Transportation Partners L.P. and The Hain Celestial Group, Inc. He serves as a trustee and member of the Executive Committee of The Caramoor Center for Music and the Arts, President Emeritus and a Life Trustee of The Jewish Museum in New York City and is a past President of the New York Chapter of the American Jewish Committee where he also served as Chair of the audit committee of the national organization. Mr. Alperin also formerly served as Chairman of the Board of Advisors of the Tucker Foundation at Dartmouth College, was President of the Board of the Stanley Isaacs Neighborhood Center in New York City, was a trustee of the Hasbro Children’s Foundation, was President of the Toy Industry Association and was a member of the Columbia University Medical School Health Sciences Advisory Council. |
Paul Brons |
Mr. Paul Brons is Independent Director of Henry Schein Inc., since April 2005. Between 1994 and 2002, Mr. Brons served as an executive board member of Akzo Nobel, N.V. From 1965 to 1994, Mr. Brons held various positions with Organon International BV, including President from 1983 to 1994 and Deputy President from 1979 to 1983. From 1975 to 1979, Mr. Brons served as the General Manager of the OTC operations of Chefaro. Both Organon and Chefaro operated within the Akzo Nobel group. Mr. Brons was honored in 1996 by Her Majesty the Queen with the decoration of Knight of the Order of Lion of the Kingdom of the Netherlands, the country’s highest civilian order, conferred for his meritorious achievements for Akzo Nobel and other international activities. During the past five years, Mr. Brons served on the Board of Directors of Almirall S.A., an international pharmaceutical company. Mr. Brons previously served as Chairman of the Supervisory Boards of Akzo Nobel Netherlands, of Organon BioSciences Netherlands and of IBM Netherlands. He was also a member of the Board of Directors of the European Federation of Pharmaceutical Industry Associations. |
Donald Kabat |
Mr. Donald J. Kabat is Independent Director of Henry Schein Inc., since May 1996. Mr. Kabat was the Chief Financial Officer of Central Park Skaters, Inc. from 1992 to 1995 and the President of D.J.K. Consulting Services, Inc. from 1995 to 2006. From 1970 to 1992, Mr. Kabat was a partner in Andersen Consulting (now known as Accenture PLC Ireland), where he practiced a broad array of specialty services including organization, profit improvement, process re-engineering and cost justification studies. During his consulting career with Andersen Consulting, Mr. Kabat helped launch an entirely new practice specialty called Change Management Services, which focused on human resource management encompassing methods to maintain continuous alignment of strategy, operations, culture and rewards. He has made numerous speeches, written articles and contributed chapters to specialized books (e.g., Budgeting: Key to Planning and Control; Management Controls for Professional Firms and The Change Management Handbook.). Mr. Kabat also serves on the boards, and chairs committees, of several not-for-profit organizations. |
Karyn Mashima |
Ms. Karyn Mashima is Independent Director of Henry Schein Inc., since May 2008. Ms. Mashima, a private consultant, served as the Senior Vice President, Strategy and Technology of Avaya Inc. from 2000 to January 2009. Prior to holding such position at Avaya, Ms. Mashima held similar positions with the Enterprise Communications unit of Lucent Technologies and AT&T from 1994 to 2000. Ms. Mashima was Vice President of Marketing at Proteon Technologies, Inc. from 1992 to 1994 and Vice President of Marketing at Network Equipment Technologies, Inc. from 1990 to 1992. From 1984 to 1990, Ms. Mashima was Product and Marketing Manager at Hewlett-Packard Company. From 1981 to 1984, Ms. Mashima was employed at Xerox Corp., where her last position was Product Manager of Xerox’s Office Systems division. Additionally, Ms. Mashima has experience in mergers and acquisitions and international business operations and relations. She was named a “Woman of Influence for 2005” by NJBiz magazine and to the “First Annual List of Tech Women to Watch” by the executive search firm Christian & Timbers. Ms. Mashima is a member of Women’s Corporate Directors International. |
Norman Matthews |
Mr. Norman S. Matthews is Independent Director of Henry Schein Inc., since February 2002. Since 1989, Mr. Matthews has worked as an independent consultant and venture capitalist. From 1978 to 1988, Mr. Matthews served in various senior management positions for Federated Department Stores, Inc., including President from 1987 to 1988. Mr. Matthews currently serves on the Board of Directors of Duff & Phelps Corp., Spectrum Brands, Inc. (as Chairman of its nominating and governance committee) and as Chairman of the Board of The Children’s Place Retail Stores, Inc. Mr. Matthews is director emeritus of Sunoco, Inc., Toys ‘R’ Us, Inc. and Federated Department Stores, Inc. and a trustee emeritus at the American Museum of Natural History. During the past five years, Mr. Matthews served on the Board of Directors of Finlay Fine Jewelry Corporation, Finlay Enterprises, Inc. and The Progressive Corporation. |
Carol Raphael |
Ms. Carol Raphael is Independent Director of Henry Schein, Inc., since August 15, 2012. Ms. Raphael served as the President and Chief Executive Officer of Visiting Nurse Service of New York from 1989 to 2011. Prior to Visiting Nurse Service of New York, Ms. Raphael held executive positions at Mt. Sinai Medical Center and in New York City government. In March 2013, Ms. Raphael was appointed by President Obama as a member of the Commission on Long-Term Care. Ms. Raphael chairs the New York eHealth Collaborative. Ms. Raphael is the Chair of the Long-Term Quality Alliance, a member of the National Quality Forum Coordinating Committee, where she chairs its Post Acute/Long-Term Care Workgroup, and is a strategic advisor to the National Committee on Quality Assurance. Ms. Raphael currently serves on several non-profit boards, including Primary Care Development Corporation, Pace University, the Medicare Rights Center and the New York City Citizens Budget Commission and as Vice-Chair of AARP’s board. Ms. Raphael is also a member of several advisory boards, including the Harvard School of Public Health’s Health Policy Management Executive Council, the New York City Age-Friendly Commission and the New York University School of Nursing Advisory Board. Ms. Raphael previously served on the Boards of Lifetime Blue Cross/Blue Shield, Future Health and the American Foundation for the Blind and was an Advanced Leadership Fellow at Harvard University in 2012. Ms. Raphael co-edited the book Home Based Care for the New Century, was a Visiting Fellow at the Kings Fund in the United Kingdom and was listed in Crain’s New York Business 50 Most Powerful Women in New York City. |
Bradley Sheares |
Dr. Bradley T. Sheares, Ph.D., is Independent Director of Henry Schein Inc., since January 2010. Dr. Sheares served as Chief Executive Officer of Reliant Pharmaceuticals, Inc., from 2007 through its acquisition by GlaxoSmithKline plc in 2007. Prior to joining Reliant, Dr. Sheares served as President of U.S. Human Health for Merck & Co. from 2001 until 2006. As a member of Merck’s management committee, Dr. Sheares had responsibility for formulating global business strategies, operations management and the development and implementation of corporate policies. He is also a director of Honeywell International (and is a member of its management development and compensation committee and retirement plan committee) and is a director and Chairman of the compensation committees at both The Progressive Corporation and Covance Inc. As a director of numerous other public companies, Dr. Sheares has been involved in succession planning, compensation, employee management and the evaluation of acquisition opportunities. During the past five years, Dr. Sheares served on the Board of Directors of IMS Health Incorporated. |
Louis Sullivan |
The Honourable Louis W. Sullivan, M.D., is Independent Director of Henry Schein Inc., since April 2003. Dr. Sullivan is President Emeritus of Morehouse School of Medicine. From 1981 to 1989 and from 1993 to 2002, Dr. Sullivan was President of Morehouse School of Medicine. From 1989 to 1993, Dr. Sullivan served as U.S. Secretary of Health and Human Services. Dr. Sullivan currently serves as Chairman of the Board of Directors of BioSante Pharmaceuticals, Inc. (as Chair of its compensation committee and as a member of its audit and finance committee and nominating and corporate governance committee) and serves on the Board of Directors of United Therapeutics Corporation (as a member of its compensation committee, nominating and governance committee and scientific committee) and Emergent BioSolutions Inc. (as Chair of its compensation committee and as a member of its nominating and corporate governance committee). Dr. Sullivan served as Chair of the President’s Commission on Historically Black Colleges and Universities from 2002 to 2009, and was Co-chair of the President’s Commission on HIV and AIDS from 2001 to 2006. Dr. Sullivan is the founding dean of Morehouse School of Medicine, the founding president of the Association of Minority Health Professions Schools and is a member of the boards of numerous charitable organizations. Dr. Sullivan is the recipient of more than 50 honorary degrees. During the past five years, Dr. Sullivan served on the Board of Directors of Inhibitex, Inc. |
Carolynne Borders |
Basic Compensation
| Name | Fiscal Year Total |
|---|---|
Stanley Bergman |
6,097,780 |
James Breslawski |
2,580,640 |
Steven Paladino |
2,346,110 |
Lonnie Shoff |
-- |
Michael Zack |
-- |
Gerald Benjamin |
2,304,860 |
Mark Mlotek |
1,946,780 |
James Harding |
-- |
Leonard David |
-- |
Michael Racioppi |
706,788 |
Stanley Komaroff |
2,177,580 |
Philip Laskawy |
-- |
Barry Alperin |
-- |
Paul Brons |
-- |
Donald Kabat |
-- |
Karyn Mashima |
-- |
Norman Matthews |
-- |
Carol Raphael |
-- |
Bradley Sheares |
-- |
Louis Sullivan |
-- |
Carolynne Borders |
-- |
As Of 28 Dec 2012
Options Compensation
| Name | Options | Value |
|---|---|---|
Stanley Bergman |
270,597 | 7,876,210 |
James Breslawski |
390,500 | 10,745,564 |
Steven Paladino |
449,000 | 12,336,175 |
Lonnie Shoff |
0 | 0 |
Michael Zack |
0 | 0 |
Gerald Benjamin |
282,618 | 8,460,384 |
Mark Mlotek |
257,029 | 3,829,019 |
James Harding |
0 | 0 |
Leonard David |
0 | 0 |
Michael Racioppi |
243,960 | 4,502,744 |
Stanley Komaroff |
68,705 | 2,551,720 |
Philip Laskawy |
0 | 0 |
Barry Alperin |
0 | 0 |
Paul Brons |
0 | 0 |
Donald Kabat |
0 | 0 |
Karyn Mashima |
0 | 0 |
Norman Matthews |
0 | 0 |
Carol Raphael |
0 | 0 |
Bradley Sheares |
0 | 0 |
Louis Sullivan |
0 | 0 |
Carolynne Borders |
0 | 0 |
| Name | Shares Traded | Price |
|---|---|---|
HARDING JAMES A |
12,000 | $39.43 |
HARDING JAMES A |
12,000 | $92.64 |
SHOFF LONNIE |
3,529 | $90.60 |
BERGMAN STANLEY M |
10,000 | $90.19 |
BRESLAWSKI JAMES P |
37,500 | $89.87 |
MLOTEK MARK E |
9,110 | $89.43 |
RACIOPPI MICHAEL S |
17,067 | $90.11 |
ALPERIN BARRY J |
7,500 | $35.49 |
BRESLAWSKI JAMES P |
37,500 | $39.43 |
DAVID LEONARD A |
7,178 | $90.19 |
ALPERIN BARRY J |
7,500 | $90.07 |
DAVID LEONARD A |
2,097 | $0.00 |
ZACK MICHAEL |
7,008 | $90.32 |
DAVID LEONARD A |
3,349 | $90.32 |
KOMAROFF STANLEY |
3,932 | $0.00 |
HARDING JAMES A |
6,000 | $39.43 |
PALADINO STEVEN |
8,762 | $90.32 |
HARDING JAMES A |
456 | $90.26 |
ZACK MICHAEL |
3,145 | $0.00 |
BERGMAN STANLEY M |
9,680 | $0.00 |
KABAT DONALD J |
4,038 | $90.00 |
KOMAROFF STANLEY |
8,455 | $90.32 |
BRONS PAUL |
1,615 | $90.32 |
PALADINO STEVEN |
3,932 | $0.00 |
HARDING JAMES A |
2,949 | $0.00 |

